The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Knowles Julius since 2021.
This trader's CIK number is 1808365.
At the time of last reporting, Knowles Julius was the Director of Keros Therapeutics, Inc.. (stock ticker symbol KROS).
Also see all insider trading activities at Keros Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | KROS | 0 | $0 | 47,651 | $2,749,605 | 0 | $0 |
| 2021 | KROS | 0 | $0 | 495,442 | $24,632,413 | 0 | $0 |
| 2020 | KROS | 1,191 | $24,987 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-13 | KROS | Buy | 1,191 | 20.98 | 24,987 |
| 2022-01-03 | KROS | Sale | 23,555 | 58.25 | 1,372,125 |
| 2022-01-04 | KROS | Sale | 20,062 | 56.97 | 1,142,932 |
| 2022-01-05 | KROS | Sale | 4,034 | 58.14 | 234,548 |
| 2021-12-02 | KROS | Sale | 25,338 | 53.42 | 1,353,657 |
| 2021-12-01 | KROS | Sale | 22,313 | 55.03 | 1,227,929 |
| 2021-11-01 | KROS | Sale | 23,803 | 42.14 | 1,003,058 |
| 2021-11-02 | KROS | Sale | 7,881 | 42.57 | 335,494 |
| 2021-11-03 | KROS | Sale | 15,967 | 42.05 | 671,412 |
| 2021-10-20 | KROS | Sale | 4,082 | 37.93 | 154,830 |
| 2021-10-19 | KROS | Sale | 4,516 | 38.27 | 172,827 |
| 2021-10-18 | KROS | Sale | 13,786 | 38.08 | 524,901 |
| 2021-10-14 | KROS | Sale | 4,383 | 40.13 | 175,889 |
| 2021-10-15 | KROS | Sale | 8,198 | 39.66 | 325,157 |
| 2021-10-04 | KROS | Sale | 3,746 | 40.06 | 150,064 |
| 2021-10-05 | KROS | Sale | 2,617 | 40.03 | 104,758 |
| 2021-10-01 | KROS | Sale | 6,323 | 40.16 | 253,931 |
| 2021-09-27 | KROS | Sale | 95,302 | 41.44 | 3,949,314 |
| 2021-07-01 | KROS | Sale | 23,834 | 41.95 | 999,907 |
| 2021-07-02 | KROS | Sale | 23,818 | 41.40 | 986,065 |
| 2021-06-02 | KROS | Sale | 11,529 | 49.90 | 575,239 |
| 2021-06-03 | KROS | Sale | 7,895 | 47.92 | 378,328 |
| 2021-06-01 | KROS | Sale | 8,812 | 53.25 | 469,265 |
| 2021-05-04 | KROS | Sale | 2,835 | 54.04 | 153,203 |
| 2021-05-03 | KROS | Sale | 44,816 | 57.76 | 2,588,482 |
| 2021-04-01 | KROS | Sale | 11,202 | 59.92 | 671,223 |
| 2021-04-05 | KROS | Sale | 27,151 | 59.56 | 1,617,113 |
| 2021-03-04 | KROS | Sale | 11,632 | 56.17 | 653,369 |
| 2021-03-03 | KROS | Sale | 12,327 | 57.38 | 707,360 |
| 2021-03-01 | KROS | Sale | 12,979 | 64.24 | 833,757 |
| 2021-03-02 | KROS | Sale | 10,711 | 59.88 | 641,353 |
| 2021-02-16 | KROS | Sale | 9,612 | 59.74 | 574,249 |
| 2021-02-17 | KROS | Sale | 16,061 | 60.78 | 976,123 |
| 2021-02-18 | KROS | Sale | 2,944 | 62.79 | 184,859 |
| 2021-02-11 | KROS | Sale | 11,561 | 65.32 | 755,176 |
| 2021-02-12 | KROS | Sale | 7,468 | 62.15 | 464,121 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Knowles Julius (Director of Keros Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.